Delivery Order SPE2DB20D1100-SPE2DB24FA4E4
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract valued at $3,314.56 by the Defense Logistics Agency (DLA) to provide FLUTICASONE PROP HFA 110 MCG 12GM pharmaceutical products. The contract has a completion date of January 26, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $1,442.25 by the Defense Logistics Agency (DLA) to provide FLUTICASONE PROP HFA 220 MCG 12GM pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,242.96 firm fixed price delivery order from the Defense Logistics Agency (DLA) for the supply of FLUTICASONE PROP HFA 110 MCG 12GM pharmaceutical products. The completion date for this order is February 28, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc., was awarded a $1,693.50 firm fixed price delivery order from the Defense Logistics Agency (DLA) on February 23, 2024. The order is for the supply of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, with a completion date of February 26, 2024. This delivery order is placed under an existing indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Fluticasone Prop HFA 220 MCG 12GM. The award, valued at $1,232.03, has a completion date of February 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract (SPE2DX15D1053|SPE2DX24F6HZX) by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to provide 4,563,943,667 units of Fluticasone Prop HFA 110 MCG 12GM. The $1,623.07 award has an ultimate completion date of March 13, 2024 and does not utilize a set-aside designation. This delivery order contract is part of a larger...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a delivery order contract worth $4,326.75 by the Defense Logistics Agency Troop Support Medical to provide FLUTICASONE PROP HFA 220 MCG 12GM pharmaceutical supplies. This contract has a completion date of February 12, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with the Defense Logistics Agency valued at up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,091.40 for the supply of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical product. This delivery order was issued under an existing indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The...
- This federal contract award is a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,238.15, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical products. The contract has an ultimate completion date of April 3, 2024 and does not include a set-aside designation....
- The Defense Logistics Agency (DLA) awarded a $4,973.03 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Fluticasone Prop HFA 110 MCG 12GM. The contract is for the delivery of pharmaceutical products and has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This order is part of a larger indefinite delivery contract (IDC) awarded by...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA4E4Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide FLUTICASONE PROP HFA 110 MCG 12GM pharmaceutical products. The award has a potential value of $2,357.21 and a completion date of February 27, 2024. This delivery order is placed under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp that has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this specific award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 2/26/24 |